RNCS Free Assessment
Saudi Arabia Registration · 5.2

MDMA Registration and the Technical File Assessment

Next: Back to Saudi Arabia Registration →

In Saudi Arabia, a device can be made available only if it is registered with SFDA and holds a Medical Device Marketing Authorization (MDMA). That is the rule set out in SFDA's requirements for marketing authorization, MDS-REQ 1. The MDMA is granted after SFDA has reviewed your technical file in what it calls a Technical File Assessment (TFA).

This page explains which devices need that full review, what the file must contain, how the submission and review run, and how to keep the process moving once SFDA starts asking questions.

Does your device need full review? MDMA versus MDL

Saudi Arabia has two registration routes, and your device class decides which one applies.

  • Medical Device Listing (MDL). A lighter route open to certain low-risk Class A devices.
  • Medical Device Marketing Authorization (MDMA). The full route for Class B, C and D devices, and for Class A devices with extra risk factors: those supplied sterile, with a measuring function, or that are reusable surgical instruments.

So classification comes before anything else. If you haven't classified your device yet, start with our guide to [SFDA device classification (MDS-G008)]. The route you land on sets the size of the file and the length of the review.

The rest of this page covers the MDMA route, because that is the one most manufacturers take.

The shortcut that closed: MDMA-1 and MDMA-2

If you read older guidance on Saudi registration, you will see two route names.

RouteWhat it allowedStatus
MDMA-1Devices already approved in GHTF reference markets (EU, US, Canada, Australia, Japan) could lean on those approvalsDiscontinued at the end of 2021
MDMA-2A full, independent Technical File Assessment and conformity evaluation by SFDA, without reliance on prior foreign approvalApplicable route since January 2022

The practical message is simple. Every device now goes through a full technical file review, whatever approvals it already holds abroad. A licence that was issued under the old GHTF route has to be renewed through a full TFA when the time comes.

That does not make your CE mark or FDA clearance worthless. It changes their role. They are no longer a substitute for SFDA's review; they are the raw material for it.

Inside the technical file: what SFDA actually reads

MDS-REQ 1 asks every manufacturer to prepare, hold and update technical documentation that shows the device meets SFDA's Essential Principles of Safety and Performance. It also expects you to run an effective quality management system to ISO 13485:2016, or an identical adopted standard.

For low-risk devices, the documentation list in MDS-REQ 1 is short. It covers:

  • device description and specification;
  • information provided by the manufacturer (labeling and instructions);
  • the Essential Principles checklist;
  • evidence of compliance with the applicable Essential Principles;
  • the risk management file;
  • the post-market surveillance plan and report.

That shortened list does not apply to IVDs, sterile devices, devices with a measuring function, reusable surgical instruments or novel devices. Those need the fuller documentation, which brings in clinical evidence and the Declaration of Conformity. Innovative devices may be exempt from some requirements after submitting the Innovative Medical Device Summary Form.

Two habits make this stage easier. First, build the file around the Essential Principles checklist, so every claim points to its evidence. Second, remember that SFDA can ask for your full technical documentation at any time, even after the MDMA is issued, and expects it within 10 days. A file that is organized from the start is a file you can send that quickly.

From GHAD to certificate: how the review runs

Everything happens electronically through SFDA's Unified Electronic System, GHAD.

  • Appoint your Authorized Representative. An overseas manufacturer applies either directly or through its AR, after the AR holds its licence through GHAD.
  • Classify the device under the rules in MDS-G008.
  • Submit the application form for Medical Device Marketing Authorization in GHAD, with the documents it asks for, and pay the fee. Several devices can be grouped in one application where the rules allow it.
  • SFDA reviews the file. The official review target is 35 working days, not counting the time you spend answering queries.
  • SFDA issues the MDMA once it is satisfied. The certificate is generally valid for three years.

For planning, treat the stages as a rough guide: about one to four weeks to appoint an AR, four to eight weeks to prepare the file, one to two weeks to submit, and two to five months for the review in practice. The review is rarely the part you can speed up. Preparation is.

Answering SFDA queries without losing weeks

Queries are a normal part of a review, not a sign that something has gone wrong. What matters is how quickly and completely you answer them, because the review clock stops while the question sits with you.

A few habits help:

  • Answer every point. Number your response to match the questions, and don't leave one for later.
  • Point to the evidence. Give the document, section and page, rather than a general reassurance.
  • Update the file when the answer changes it. If a reply reveals a gap, fix the technical file as well, so the two stay consistent.
  • Route everything through one person. Agree with your Authorized Representative who receives queries, who drafts replies and who signs them off.
  • Know your technical owner. Queries often need a quick answer from engineering, regulatory or clinical, and the delay is usually in finding the person.

The cheapest query is the one you never receive. That is why we read a file as the reviewer would before it goes in.

Your CE or FDA file is a head start, not a finish line

Most of what SFDA asks for already sits in a well-built CE or FDA file: the device description, risk management, verification and validation, clinical evidence and labeling. So you rarely start from nothing.

The work is in the translation:

  • Re-map the content to SFDA's structure and its Essential Principles checklist.
  • Close the gaps. Look for anything SFDA expects that your original file treats lightly, such as the post-market surveillance plan and report.
  • Check the labeling. Language rules differ, and the labeling in the file must match what will be on the market in Saudi Arabia.
  • Align the class. Your SFDA class may differ from your EU or US class, and the evidence you present should match the rules that apply.

If the label carries a mark such as CE, SFDA may ask for proof that the device actually meets the corresponding requirements. Be ready to show it.

None of this needs to be heavy. Done carefully, reusing your existing file is the quickest way to a submission SFDA can follow.

Six ways a review stalls

Most delays come from a short list of avoidable problems.

  • Assuming CE or FDA approval is enough. Since January 2022, every device gets a full technical file review.
  • Submitting a file that is organized for a different regulator. Reviewers shouldn't have to hunt for evidence.
  • Leaving classification unsettled. A late change of class changes the documents SFDA expects.
  • Inconsistent documents. The labeling, the IFU, the file and the marketing materials should tell the same story.
  • Slow or partial answers to queries. The review clock waits for you.
  • No quality system evidence. MDS-REQ 1 expects an effective QMS to ISO 13485:2016, so have that evidence ready to show.

Insights from Practice

[To add: your own hands-on experience. Ideas: the query SFDA raises most often, how long a typical file took to prepare, a CE file section that needed the most rework, or a response that closed a query quickly.]

MDMA registration: your questions answered

Can I use my CE certificate or FDA clearance instead of a full review? No. Since 2022, every device goes through a full SFDA Technical File Assessment. Your CE or FDA documentation is still very useful, because most of the file can be reused and reformatted.

Who can submit the application? A local manufacturer, an overseas manufacturer, or the overseas manufacturer's Authorized Representative, once the required licence is held through GHAD.

Do I need an ISO 13485 quality system? MDS-REQ 1 expects manufacturers to maintain an effective quality management system according to ISO 13485:2016, or an identical adopted standard.

Can SFDA ask for my file after the MDMA is issued? Yes. SFDA may request all technical documentation at any time, and you must provide it within 10 days.

How long is an MDMA valid? Generally three years. A renewal request can be submitted 90 days before expiry, and the certificate must be renewed before it expires.

How long does the review take? SFDA's official target is 35 working days, excluding the time you spend answering queries. In practice, plan for two to five months.

Ready to build a file SFDA can follow?

Send us your device description, intended use and the class you expect. We'll tell you plainly which route we think fits, how much of your CE or FDA file you can reuse, and where the risks sit, before you commit to anything.

[Talk to our team] · [Request a file review]

Last reviewed: November 2026

Contact us today

Tell us about your device and target market. Our regulatory specialist, not a salesperson, will reply within one business day.

Get Your Free Regulatory Assessment